The cannabis industry continues to see movement amongst players big and small. Seeking stronger economies of scale, more complementary assets, and access to new product development, firms in the CBD and hemp space are joining forces via mergers and acquisitions. As new deals abound in the CBD space and more industries open to the idea of hemp-infused products, CBD wellness brand Phaze Sports and its parent company Real Brands (OTCMKTS: RLBD) could be a strong buy for investors, including but not limited to one of its major shareholder Turning Point Brands (NYSE: TPB).

ACQUISITIONS IN THE INDUSTRY

Reported by NutraIngredients USA in October of last year, the wave of acquisitions of small CBD product firms is growing. Looking to capitalize on the success and assets of smaller firms, several CBD brands, like New Jersey-based CanaFarma Hemp, are reaching favorable terms to acquire up-and-coming companies partially or wholly. 2020 wrapped with several high-profile acquisitions, and 2021 followed this trend. If these trends continue, there stands to be huge returns made for investors who get in earlier on any firm who is party to an acquisition or merger.

The industry is growing through mergers that are bringing about new products and innovations in the CBD space. Most recently, Real Brands (OTCMKTS: RLBD) has brought hemp-infused nutrition and wellness products to the athletic performance arena. By using CBD and hemp rather than OTC pain relivers or even prescription pain killers, Phaze Sports is helping athletes level-up and compete pain free and well-rested.

More on that in a bit.

ACQUISITIONS COULD CREATE SHAREHOLDER WEALTH

If a firm is doing well and finding success with its products in a given market, then why seek out a merger or acquisition deal? It's fairly straight forward: The long-term return generated by two companies joining forces, is more than the sum of its parts. It is, quite possibly, exponential.

Firms take part in mergers and acquisitions, as a means to, ultimately, increase shareholder wealth. A merger or acquisition holds several benefits, all of which are aimed at boosting overall profitability and market share. The opportunity for increased holdings value is that much stronger in emerging and growing markets like the CBD industry, which is projected to reach more than $20 billion in sales by the end of 2024. For players like Real Brands (OTCMKTS: RLBD) and their Phaze Sports product line, the outlook for growth is twice as sweet, since they also find opportunity in the sports nutrition market, which should hit $17 billion in sales by the end of this year.

PHAZE SPORTS AS A PRODUCT

Launched by Real Brands (OTCMKTS: RLBD) in Q4 of 2021, Phaze Sports products are "formulated to enhance the performance of athletes both professional and amateur" through "a wide assortment of functional, hemp-infused topicals and edibles designed for each stage of an athlete's typical day.

Because of this focus on the four stages of an athlete's typical day (Rise. Compete. Recover. Sleep), RLBD has the opportunity of serving its customers from the moment they "rise" until they put their heads on the pillow at night. They are more than a performance brand-they will become part of the customer's daily routine and lifestyle.

PHAZE SPORTS (RLBD) AS AN INVESTMENT

RLBD recently announced their listing on the OTCQB, making them much more appealing to investors and the market at-large. This listing comes just weeks after a Top News Guide interview with RLBD CEO Thom Kidrin was released, wherein Kidrin stated he would announce five new deals for Real Brands (OTCMKTS: RLBD) once the firm was approved for listing on the OTCQB. As the market awaits the announcement of these potentially blockbuster deals, RLBD's stock has taken off and currently sits at $0.0442 per share. As trends in the CBD have seemingly no cap on them, this stock could climb higher as RLBD's Phaze Sports products become household names.

More on RLBD here: https://topnewsguide.com/2021/12/16/real-brands-inc-s-otcmkts-rlbd-ceo-anticipates-revised-filing-for-otcqb-up-list-by-years-end/

Disclaimers: Capital Gains Report 'CGR' is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by CGR is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall CGR. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by CGR., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. CGR. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, CGR., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated up to fifteen thousand dollars via wire transfer by Washington Capital to produce and syndicate content for RLBD. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

CONTACT: To educate and attract more investors contact us at:

Mark McKelvie

editorcapitalgainsreport@gmail.com

(754) 233-0966

.

(C) 2022 M2 COMMUNICATIONS, source M2 PressWIRE